Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
(NASDAQ: ORKA) Delayed: 69.89 +1.42 (2.07%)
Previous Close $68.47    52 Week High $ 
Open $68.32    52 Week Low $ 
Day High $71.09    P/E N/A 
Day Low $67.68    EPS $ 
Volume 781,477